Therapeutic base editing and prime editing of COL7A1 mutations in recessive dystrophic epidermolysis bullosa
Author:
Funder
National Research Foundation of Korea
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine
Reference66 articles.
1. Epidermolysis bullosa;Bardhan;Nat. Rev. Dis. Prim.,2020
2. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility;Has;Br. J. Dermatol.,2020
3. Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure;Wang;Mol. Ther.,2013
4. Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms;Nyström;EMBO Mol. Med.,2015
5. PDGFRα-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia;Tamai;Proc. Natl. Acad. Sci. USA,2011
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Highly efficient CRISPR/Cas9‐mediated exon skipping for recessive dystrophic epidermolysis bullosa;Bioengineering & Translational Medicine;2024-01-17
2. Applications of CRISPR technologies to the development of gene and cell therapy;BMB Reports;2024-01-04
3. Successful Correction by Prime Editing of a Mutation in the RYR1 Gene Responsible for a Myopathy;Cells;2023-12-22
4. Prime editing: current advances and therapeutic opportunities in human diseases;Science Bulletin;2023-12
5. CRISPR-Cas9-based non-viral gene editing therapy for topical treatment of recessive dystrophic epidermolysis bullosa;Molecular Therapy - Methods & Clinical Development;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3